Suppr超能文献

非缺血性心肌病中心脏再同步治疗:希氏束起搏与双心室起搏的对比非随机研究。

Cardiac resynchronization therapy in non-ischemic cardiomyopathy: a comparative non-randomized study of His Bundle pacing versus biventricular pacing.

机构信息

Arrhythmia Unit, Department of Cardiology, Hospital Juan Ramon Jimenez (HJRJ)), Ronda Exterior Norte s/n. 21005, Huelva, Spain.

Department of Cardiology, HJRJ, Huelva, Spain.

出版信息

J Interv Card Electrophysiol. 2023 Aug;66(5):1077-1084. doi: 10.1007/s10840-022-01192-2. Epub 2022 Mar 29.

Abstract

BACKGROUND

Cardiac resynchronization therapy (CRT) via permanent His bundle pacing (pHBP) has gained acceptance globally, but robust studies comparing pHBP-CRT with classic CRT are lacking. In this study, we aimed to compare the improvement in left ventricular ejection fraction (LVEF) after pHBP-CRT versus classic CRT.

METHODS

This was a single-center study comparing a prospective series of pHBP-CRT with a historical series of CRT via classic biventricular pacing (BVP). Patients with non-ischemic cardiomyopathy, baseline LVEF < 35%, left bundle branch block (LBBB), and CRT indications were selected.

RESULTS

Fifty-one patients underwent classic CRT and 52 patients underwent pHBP-CRT. In the classic CRT group, the median (interquartile range) basal LVEF was 30% (IQR, 29-35%) before implantation and 40% (35-48%) at follow-up. In the pHBP-CRT group, the median basal LVEF was 30% (28-34%) before implantation and 55% (45-60%) at follow-up, with significant differences between both modalities at follow-up (p = 0.001). The median long term His recruitment threshold with LBBB correction was 1.25 (1-2.5) V at 0.4 ms in cases of pHBP-CRT, compared to a left ventricular coronary sinus threshold of 1.25 (1-1.75) V in cases of classic CRT (p = 0.48). After CRT, the median paced QRS was 135 (120-145) ms for pHBP-CRT versus 140 (130-150) ms for BVP-CRT (p = 0.586).

CONCLUSIONS

The improvement in LVEF was superior with pHBP-CRT than with classic CRT. The thresholds at follow-up were similar in both groups.

摘要

背景

通过永久希氏束起搏(pHBP)的心脏再同步治疗(CRT)已在全球范围内得到认可,但缺乏 pHBP-CRT 与经典 CRT 相比的稳健研究。本研究旨在比较 pHBP-CRT 与经典 CRT 后左心室射血分数(LVEF)的改善。

方法

这是一项单中心研究,比较了前瞻性 pHBP-CRT 系列与经典双心室起搏(BVP)的历史 CRT 系列。选择非缺血性心肌病、基线 LVEF<35%、左束支传导阻滞(LBBB)和 CRT 适应证的患者。

结果

51 例患者接受经典 CRT,52 例患者接受 pHBP-CRT。在经典 CRT 组中,植入前中位(四分位间距)基础 LVEF 为 30%(29-35%),随访时为 40%(35-48%)。在 pHBP-CRT 组中,植入前中位基础 LVEF 为 30%(28-34%),随访时为 55%(45-60%),两种方式在随访时差异有统计学意义(p=0.001)。pHBP-CRT 中伴有 LBBB 矫正的长期希氏束募集阈值中位数为 1.25(1-2.5)V 时为 0.4ms,而经典 CRT 中左心室冠状窦阈值中位数为 1.25(1-1.75)V(p=0.48)。在 CRT 后,pHBP-CRT 的起搏 QRS 中位数为 135(120-145)ms,而 BVP-CRT 的起搏 QRS 中位数为 140(130-150)ms(p=0.586)。

结论

pHBP-CRT 比经典 CRT 更能改善 LVEF。两组的随访阈值相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验